Sign In | Join Free | My himfr.com
Home > Mouse Monoclonal Antibody >

Recombinant 2019-NCoV Mouse Monoclonal Antibody Spike RBD Protein

    Buy cheap Recombinant 2019-NCoV Mouse Monoclonal Antibody Spike RBD Protein from wholesalers
     
    Buy cheap Recombinant 2019-NCoV Mouse Monoclonal Antibody Spike RBD Protein from wholesalers
    • Buy cheap Recombinant 2019-NCoV Mouse Monoclonal Antibody Spike RBD Protein from wholesalers
    • Buy cheap Recombinant 2019-NCoV Mouse Monoclonal Antibody Spike RBD Protein from wholesalers
    • Buy cheap Recombinant 2019-NCoV Mouse Monoclonal Antibody Spike RBD Protein from wholesalers

    Recombinant 2019-NCoV Mouse Monoclonal Antibody Spike RBD Protein

    Ask Lasest Price
    Brand Name : New Life
    Model Number : 40592-MM57
    Certification : ISO13485
    Price : USD
    Payment Terms : T/T, Western Union
    Supply Ability : 1108mg/month
    Delivery Time : 10-35days
    • Product Details
    • Company Profile

    Recombinant 2019-NCoV Mouse Monoclonal Antibody Spike RBD Protein


    Recombinant 2019-nCoV Mouse Monoclonal Antibody Spike RBD Protein


    Background


    The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. It's been reported that SARS-CoV-2 (COVID-19 coronavirus, 2019-nCoV) can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. The main functions for the Spike protein are summarized as: Mediate receptor binding and membrane fusion; Defines the range of the hosts and specificity of the virus; Main component to bind with the neutralizing antibody; Key target for vaccine design; Can be transmitted between different hosts through gene recombination or mutation of the receptor binding domain (RBD), leading to a higher mortality rate. This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cellsobtained from a mouse immunized with purified, Recombinant SARS-CoV-2 (2019-nCoV) Spike RBD-mFc Protein. The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.


    Name

    2019-nCoV Mouse Monoclonal Antibody Spike RBD Protein


    ApplicationInvitro research and manufacture use;
    membrane assay, ELISA assay,
    Perseverative

    1 0.02% sodium azide.


    Buffer:1X PBS buffer
    Storage:Short-term: refrigerated at 2-8 ºC; long term: frozen at or
    below -20 ºC.
    Concentration1.0 mg/mL
    Expiration Date:14 days refrigerated at -2-8ºC
    and two years frozen at -20 ºC
    or below from production date.
    To be evaluated independently
    FeatureHigh Sensitivity and Specificity

    Specification Data


    Description:Monoclonal Antibody to Acetaminophene
    Clone:SARS-CoV-2 (2019-nCoV) Spike RBD Protein
    Source:Mouse IgG2b
    Immunogen:

    SARS-CoV-2 (2019-nCoV) Spike S1 Protein

    Formulation:

    0.2 μm filtered solution in PBS

    Purification:DEAE chromatography
    Concentration:1.0 mg/mL (OD280 nm, E0.1% = 1.40)
    Affinity Constant:Not determined
    Buffer:0.015M potassium phosphate buffer, 0.85% NaCl, 0.05% NaN3 pH=7.2
    Pairing Assays:N/A
    Purity:>90% by HPLC and SDS-PAGE
    Application:

    Neutralization, ELISA

    Storage:2-8o C for 1 year. Store at -200 C for long term.

    The neutralization activity is Measured by microneutralization assay in vitro. The virus microneutralizaiton (MN) test was performed on 293T-ACE2 cells infected with SARS-CoV-2 (2019-nCoV) Spike Pseudovirus under treatment of serial dilutions of neutralizing antibody. The infection was neutralized by increasing concentrations of Anti-SARS-CoV-2 Neutralizing Antibody (Catalog# 40592-MM57). Rate of inhibition was determined by comparing the Relative Light Unit (RLU) of Luciferase reporter in different antibody concentrations. The IC50 is typically 0.41 µg/mL.


    Loaded SARS-CoV-2 (2019-nCoV) Spike RBD-His Recombinant Protein,Biotinylated on SA Biosensor, can bind SARS-CoV-2 (2019-nCoV) Spike Neutralizing Antibody, Mouse MAb with an affinity constant of 0.07 nM as determined by Octet RED System.


    Loaded SARS-CoV-2 (2019-nCoV) Spike S1-His Recombinant Protein,Biotinylated on SA Biosensor, can bind SARS-CoV-2 (2019-nCoV) Spike Neutralizing Antibody, Mouse MAb with an affinity constant of 0.05 nM as determined by Octet RED System


    FAQ

    1. Q:Are you a factory or trading company?
    A: We are a factory, we have rich experience for manufacturing Medical Device more than 10 years.
    2.Q:Where is your factory located? How can i visit there?
    A: Our factory is located in Jiaxing city, Zhejiang Province, China.
    It is about more than 1 hours from Shanghai.

    2. 3.Q:Can you make samples?
    A: Yes, we can make samples for you.
    4.Q:How does your factory do as quality control?
    A: Quality is the lift of our factory. We have inspector in different post, and there are three inspectors before packing to get best quality products.
    5.Q: How is your post market service ?
    A: If any damaged rings in the course of carriage, with the checking it's our mistake, we will take full responsibility to compensate the customers.

    6.Q:Can you do OEM for us?
    A: Certainly. We also can build the moulding for our new customer.

    7.Q:Does the price include freight?
    A:No, please choose the express service provider or negotiate with us.


    Quality Recombinant 2019-NCoV Mouse Monoclonal Antibody Spike RBD Protein for sale
    Inquiry Cart 0
    Send your message to this supplier
     
    *From:
    *To: Orient New Life Medical Co.,Ltd.
    *Subject:
    *Message:
    Characters Remaining: (0/3000)